Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/1998
06/09/1998US5763411 Solid support coated with fibrin monomer readily capable of being converted to fibrin polymer sealant or hemostat
06/09/1998US5763410 Kit for preparing a fibrin sealant
06/09/1998US5763406 Method for the treatment of conditions caused by herpes virus infections
06/09/1998US5763403 Poisons, proteins with amino acid sequences
06/09/1998US5763401 Stabilized albumin-free recombinant factor VIII preparation having a low sugar content
06/09/1998US5763400 Controlling insects
06/09/1998US5763397 Glycopeptides, a process for their preparation and their use
06/09/1998US5763389 Using an alkaline aqueous extractant having a ph above the isoelectric point of the vegetable protein material; removing insolubles and contacting with a hydrolase; anticarcinogenic agents
06/09/1998US5763284 Methods for peptide synthesis and purification
06/09/1998US5763276 Processes for the purification of human recombinant decorin and the detection of guandinium ions
06/09/1998US5763272 Amino acid sequence of cells for monoclonal antibodies
06/09/1998US5763271 Vasodilatory and immune suppressant peptides
06/09/1998US5763269 Recombinant infectious bovine rhinotrocheitis virus
06/09/1998US5763268 Hepatitis delta virus compositions and expression vectors
06/09/1998US5763266 Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells
06/09/1998US5763256 Subtilisin-type serine protease having catalytic serine at or near amino terminus replaced by or converted to cysteine, specified proline replaced with different helix-forming amino acid
06/09/1998US5763253 Methods of preparing tissue plasiminogen activator derivative composition
06/09/1998US5763250 Chimeric toxins
06/09/1998US5763247 Nucleotide fragments and uses thereof for obtaining bactericide-producing compositions
06/09/1998US5763243 Using a genetic engineered dna to repress the dominant negative gene
06/09/1998US5763241 Insect resistant plants
06/09/1998US5763226 Bacillus cereus enterotoxin and method of use
06/09/1998US5763225 Synthesis of peptides as cloned ubiquitin extensions
06/09/1998US5763224 Genetic engineered complementary dna
06/09/1998US5763223 DNA encoding a cytokine that induces apoptosis
06/09/1998US5763220 Human apoptosis-related calcium-binding protein
06/09/1998US5763219 Cyclin E variants and use thereof
06/09/1998US5763218 Nucleic acid encoding novel human G-protein coupled receptor
06/09/1998US5763217 Method of using, process of preparing and composition comprising recombinant herpesvirus vectors
06/09/1998US5763216 Introducing an expression vector comprising a promoter linked with a dna molecule, into a host cell to produce genetic engineered cell, culturing the transfored cell, isolating the reduced folate carrier protein from cultured transformed cell
06/09/1998US5763215 Method of removing N-terminal amino acid residues from eucaryotic polypeptide analogs and polypeptides produced thereby
06/09/1998US5763214 Fibroblast growth factor 11
06/09/1998US5763213 Sensory and motor neuron derived factor (SMDF)
06/09/1998US5763212 Binding low molecular mass cell penetrating ligand to protein
06/09/1998US5763211 Polynucleotide which encodes receptor polypeptide
06/09/1998US5763210 Recombinant production of interferon-gamma binding proteins
06/09/1998US5763209 Methods and materials relating to the functional domains of DNA binding proteins
06/09/1998US5763195 Method and compositions for making ACSF and ACSF antagonists
06/09/1998US5763190 Detecting the human immunodeficiency virus type i protein
06/09/1998US5763189 Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds
06/09/1998US5763183 Allelic variation of the serotonin 5HT7 receptor
06/09/1998US5763182 RPDL protein and DNA encoding the same
06/09/1998US5763177 Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
06/09/1998US5763173 Nucleic acid ligand inhibitors to DNA polymerases
06/09/1998US5763169 Nucleic acid probes for the detection and identification of fungi
06/09/1998US5763166 Gene associated with X linked Kallmann syndrome and diagnostic applications therefrom
06/09/1998US5763165 Method for determining lung adenocarcinomas by assaying for one or more of MAGE-1, MAGE-2 and MAGE-3
06/09/1998US5763164 Immunogenic cancer proteins and peptides and methods of use
06/09/1998US5763160 Detecting antibodies to hiv and neutralizing antibodies to hiv-gp120 in an immunoassay by using polypeptide or conjugate of polypeptide, polylysine of peptide 127 or mixtures
06/09/1998US5763159 Hepatitis-C virus testing
06/09/1998US5763156 Effective in regulating inflammatory platelet and endothelial sitmulatory and coagulopathic responses by modulating the activity of the c5b-9 complex of the human plasma complement system by adding a fluorescent potentiometric dye
06/09/1998US5763155 Method for determining lung adenocarcinomas by assaying for one or more of MAGE-1, MAGE-2 and MAGE-3 gene products
06/09/1998US5762965 Vaccines against intracellular pathogens using antigens encapsulated within biodegradble-biocompatible microspheres
06/09/1998US5762941 Modified shigella having reduced pathogenicity
06/09/1998US5762939 Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
06/09/1998US5762938 Modified recombinant vaccinia virus and expression vectors thereof
06/09/1998US5762937 Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
06/09/1998US5762934 Clostridium difficile toxin disease therapy
06/09/1998US5762927 Exposing primate to immunotoxin, administering lymph node lymphocytes, transplanting organ
06/09/1998US5762924 Wherein heterologous dna is located in the genome at the site of spindle protin gene; pesticides, insecticides
06/09/1998US5762923 Stabilized interferon alpha solutions
06/09/1998US5762805 Transferring matter to or from blood, semipermeable membranes, filters and controlling flow
06/04/1998WO1998023964A1 METHOD TO DETECT IgE
06/04/1998WO1998023963A1 Methods and reagents for determining protein s
06/04/1998WO1998023960A1 Assay method for peptide specific t-cells
06/04/1998WO1998023782A2 A new ets-related gene overexpressed in human breast and epithelial cancers
06/04/1998WO1998023781A1 Ligand detection system and methods of use thereof
06/04/1998WO1998023780A1 Methods for diagnosing and treating diabetes
06/04/1998WO1998023779A1 The brca1 and 1a1.3b promoters are parallel elements of a genomic duplication at 17q21
06/04/1998WO1998023775A2 Dna for evaluating the progression potential of cervical lesions
06/04/1998WO1998023771A1 A new eia test using non-dentured hiv antigen for early detection of hiv infection
06/04/1998WO1998023764A1 Truncated cbh i promoter from trichoderma reesei and use thereof
06/04/1998WO1998023763A1 Heterologous antigens in live cell v. cholerae strains
06/04/1998WO1998023762A2 Methods of producing a recombinant protein
06/04/1998WO1998023759A2 Identification of inhibitors that prevent access of telomerase to chromosomal terminus
06/04/1998WO1998023755A1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
06/04/1998WO1998023754A1 Process for the expression of genes of the dengue viruses
06/04/1998WO1998023753A1 Systems for determining substances active against hpv-associated diseases
06/04/1998WO1998023752A2 Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses
06/04/1998WO1998023751A1 Processed polypeptides with il-16 activity, processes for their production and their use
06/04/1998WO1998023750A2 Mammalian chemokines
06/04/1998WO1998023749A1 Fibroblast growth factor-13
06/04/1998WO1998023748A1 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3)
06/04/1998WO1998023747A2 Isolated mammalian dendritic cell genes; related reagents
06/04/1998WO1998023746A1 Antibody mutants
06/04/1998WO1998023745A1 Human sqm1 protein homolog comprising a cell adhesion protein
06/04/1998WO1998023744A1 Novel human rna-binding protein
06/04/1998WO1998023743A1 Murine guanine nucleotide exchange factor - (mngef) and human homologues thereof
06/04/1998WO1998023742A1 A NOVEL CLONED GABA-RECEPTOR SUBUNIT cDNA SEQUENCE AND STABLY CO-TRANSFECTED CELL LINES
06/04/1998WO1998023741A1 Mutants of the lag-3 proteins, products for the expression of these mutants and use
06/04/1998WO1998023740A1 Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis
06/04/1998WO1998023739A1 Novel gene encoding male-transplantation antigen
06/04/1998WO1998023738A2 Novel prokaryotic polynucleotides, polypeptides and their uses
06/04/1998WO1998023735A1 Immune responses using compositions containing stress proteins
06/04/1998WO1998023730A1 Compounds and methods for treating cancer
06/04/1998WO1998023644A1 Peptide derivatives
06/04/1998WO1998023643A1 Multimeric erythropoietin with increased biological activity
06/04/1998WO1998023642A1 Genes encoding transcriptional regulatory proteins from trichoderma reesei and uses thereof
06/04/1998WO1998023641A1 Dna encoding lepidopteran-active delta-endotoxins and its use
06/04/1998WO1998023640A1 Procedure for the purification and refolding of hpv proteins
1 ... 2385 2386 2387 2388 2389 2390 2391 2392 2393 2394 2395 2396 2397 2398 2399 2400 2401 2402 2403 2404 2405 ... 2916